Get started
Author

Rosie Bradley

Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials
2017 · Bernard Asselain, William Barlow, et al. · The Lancet Oncology · 1,122
PDF
Increasing the dose intensity of chemotherapy by more frequent administration or sequential scheduling: a patient-level meta-analysis of 37 298 women with early breast cancer in 26 randomised trials
2019 · Richard Gray, Rosie Bradley, et al. · The Lancet · 401
PDF
Trastuzumab for early-stage, HER2-positive breast cancer: a meta-analysis of 13 864 women in seven randomised trials
2021 · Rosie Bradley, Jeremy Braybrooke, et al. · The Lancet Oncology · 354
PDF
Anthracycline-containing and taxane-containing chemotherapy for early-stage operable breast cancer: a patient-level meta-analysis of 100 000 women from 86 randomised trials
2023 · Jeremy Braybrooke, Rosie Bradley, et al. · The Lancet · 214
PDF
Minocycline at 2 Different Dosages vs Placebo for Patients With Mild Alzheimer Disease
2019 · Robert Howard, Olga Zubko, et al. · JAMA Neurology · 194
PDF
Radiotherapy to regional nodes in early breast cancer: an individual patient data meta-analysis of 14 324 women in 16 trials
2023 · Carolyn Taylor, David Dodwell, et al. · The Lancet · 172
PDF
The effectiveness and cost-effectiveness of assistive technology and telecare for independent living in dementia: a randomised controlled trial
2020 · Robert Howard, Rebecca Gathercole, et al. · Age and Ageing · 67
PDF
Assistive technology and telecare to maintain independent living at home for people with dementia: the ATTILA RCT
2021 · Rebecca Gathercole, Rosie Bradley, et al. · Health Technology Assessment · 65
PDF
Antipsychotic treatment of very late-onset schizophrenia-like psychosis (ATLAS): a randomised, controlled, double-blind trial
2018 · Robert Howard, Elizabeth Cort, et al. · The Lancet Psychiatry · 64
PDF
Abstract S4-07: Effects of bisphosphonate treatment on recurrence and cause-specific mortality in women with early breast cancer: A meta-analysis of individual patient data from randomised trials
2013 · R Coleman, M Gnant, et al. · Cancer Research · 62
Extending the duration of endocrine treatment for early breast cancer: patient-level meta-analysis of 12 randomised trials of aromatase inhibitors in 22 031 postmenopausal women already treated with at least 5 years of endocrine therapy
2025 · Jeremy Braybrooke, Rosie Bradley, et al. · The Lancet · 41
Effects of ovarian ablation or suppression on breast cancer recurrence and survival: Patient-level meta-analysis of 14,993 pre-menopausal women in 25 randomized trials.
2023 · Richard G. Gray, Rosie Bradley, et al. · Journal of Clinical Oncology · 36
Abstract GS1-01: Increasing the dose density of adjuvant chemotherapy by shortening intervals between courses or by sequential drug administration significantly reduces both disease recurrence and breast cancer mortality: An EBCTCG meta-analysis of 21,000 women in 16 randomised trials
2018 · R Gray, R Bradley, et al. · Cancer Research · 32
Assessment of need and practice for assistive technology and telecare for people with dementia—The ATTILA (Assistive Technology and Telecare to maintain Independent Living At home for people with dementia) trial
2019 · Kirsty Forsyth, Catherine Henderson, et al. · Alzheimer s & Dementia Translational Research & Clinical Interventions · 29
PDF
The impact of assistive technology on burden and psychological well‐being in informal caregivers of people with dementia (ATTILA Study)
2020 · Anna Davies, Stefano Brini, et al. · Alzheimer s & Dementia Translational Research & Clinical Interventions · 27
PDF
Minocycline 200 mg or 400 mg versus placebo for mild Alzheimer’s disease: the MADE Phase II, three-arm RCT
2020 · Robert Howard, Olga Zubko, et al. · Efficacy and Mechanism Evaluation · 17
PDF
Do tumor infiltrating lymphocytes (TILs) predict benefits from trastuzumab therapy for HER2 positive breast cancer? Meta-analysis of individual patient data from 4097 women in 5 trials.
2023 · Robert Kerrin Hills, Rosie Bradley, et al. · Journal of Clinical Oncology · 12
Amisulpride for very late-onset schizophrenia-like psychosis: the ATLAS three-arm RCT
2018 · Robert Howard, Elizabeth Cort, et al. · Health Technology Assessment · 10
PDF
Abstract PD14-08: Effectiveness of aromatase inhibitors versus tamoxifen in lobular compared to ductal carcinoma: Individual patient data meta-analysis of 9328 women with central histopathology, and 7654 women with e-Cadherin status
2022 · Robert K Hills, Steffi Oesterreich, et al. · Cancer Research · 7
Neo-adjuvant versus adjuvant chemotherapy in early breast cancer: EBCTCG patient-level meta-analysis of long-term outcomes among 4756 women in 10 randomised trials
2018 · Paul McGale, Carolyn Taylor, et al. · European Journal of Surgical Oncology · 6
Patient-level meta-analysis of randomized trials of aromatase inhibitors (AI) versus tamoxifen (Tam).
2014 · John F. Forbes, Mitchell Dowsett, et al. · Journal of Clinical Oncology · 6
Effects of ovarian ablation or suppression on breast cancer recurrence and survival: patient-level meta-analysis of 15 000 women in 23 randomised trials
2026 · Rosie Bradley, Jeremy Braybrooke, et al. · The Lancet · 5
Abstract GS2-06: Taxane with anthracycline versus taxane without anthracycline: An individual patient-level meta-analysis of 16,500 women with early-stage breast cancer in 13 randomised trials
2022 · Jeremy Braybrooke, Rosie Bradley, et al. · Cancer Research · 5
Abstract GS2-04: Improvements in long-term outcome for women with estrogen receptor positive (ER+) early stage breast cancer treated with 5 years of endocrine therapy: Analyses of 82,598 women in the Early Breast Cancer Trialists’ Collaborative Group (EBCTCG) database
2020 · Hongchao Pan, Jeremy Braybrooke, et al. · Cancer Research · 4
Abstract GS2-04: Aromatase inhibitors versus tamoxifen in pre-menopausal women with estrogen receptor positive early stage breast cancer treated with ovarian suppression: A patient level meta-analysis of 7,030 women in four randomised trials
2022 · Rosie Bradley, Jeremy Braybrooke, et al. · Cancer Research · 3
Works count: 41
Citation count: 2,955
H-index: 16
I10-index: 18
Year
Topic
Type